In Fig. 3c where a single pulse of 20 Gy was delivered on day 14, there is a noticeable benefit in tumor control for group 4 (anti-PD-L1) compared to group 3 (without anti-PD-L1), which becomes apparent 1–2 days after the first pulse. Here, CD274 is linked to neoplasm.